Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05908396 · TERMINATED
Trial details
- NCT number
- NCT05908396
- Sponsor
- IGM Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-29
- Primary completion
- 2024-02-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.